Florian Clatot

Inserm — France

Medicine · Health Sciences

35h-index3.9kcitations252works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(65), Breast Cancer Treatment Studies(58), Cancer Genomics and Diagnostics(56), Cancer Cells and Metastasis(48), Head and Neck Cancer Studies(31)

Publications250 total

The role of body mass index at diagnosis in patients with inflammatory breast cancer
The Breast·2025Open Access
Defining a need for rapid response and practical guidance for recurrent and metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) management in France: A Delphi consensus
PLoS ONE·2025· 1 citedOpen Access
666MO Reliability of cerebrospinal fluid (CSF) ctDNA as a surrogate for tumor mutational profiling in central nervous system (CNS) metastases: Results from the BrainStorm (OncoDistinct006) study
Annals of Oncology·2025
Prognostic value of circulating HER2 extracellular domain in patients with HER2-positive metastatic breast carcinoma treated with TDM-1 (trastuzumab emtansine)
Clinical & Translational Oncology·2025· 1 cited
Risk factors for fractures after marginal mandibulectomy for head and neck cancer multicentre study
Oral Oncology·2025· 1 citedOpen Access
Induction of tertiary lymphoid structures in tumor microenvironment to improve anti-tumoral immune checkpoint blockade efficacy
European Journal of Cancer·2025· 7 citedOpen Access
Petosemtamab (MCLA-158) with pembrolizumab as first-line (1L) treatment of PD-L1+ recurrent/metastatic (r/m) head and neck squamous cell carcinoma (HNSCC): Phase 2 trial.
Journal of Clinical Oncology·2025· 7 cited
First-line durvalumab plus chemotherapy with or without oleclumab for locally advanced or metastatic triple-negative breast cancer: SYNERGY overall survival and circulating tumor DNA analysis.
Journal of Clinical Oncology·2025
Impact of pembrolizumab on ovarian function in young triple-negative breast cancer patients treated with chemo-immunotherapy
Breast Cancer Research and Treatment·2025· 6 cited
Retrospective multicentric survival analysis of patients receiving TPEx regimen as first-line treatment of recurrent and/or metastatic head and neck squamous cell carcinoma
ESMO Open·2025· 2 citedOpen Access
Impact of pembrolizumab on ovarian function in young triple negative breast cancer patients treated with chemo-immunotherapy
2025Open Access
886P Retrospective multicentric survival analysis of patients receiving TPEx regimen (docetaxel, platinum and cetuximab) as first line treatment of recurrent or metastatic squamous cell carcinoma of the head and neck
Annals of Oncology·2024
282P Impact of pembrolizumab on ovarian function in young triple negative breast cancer patients treated with chemo-immunotherapy
Annals of Oncology·2024Open Access
883P Oral rehabilitation after mandibular reconstruction for head and neck malignancy: A multicenter study
Annals of Oncology·2024
Prognostic value of HPV circulating tumor DNA detection and quantification in locally advanced cervical cancer
Frontiers in Oncology·2024· 4 citedOpen Access
Petosemtamab (MCLA-158) with pembrolizumab as first-line (1L) treatment of recurrent/metastatic (r/m) head and neck squamous cell carcinoma (HNSCC): Phase 2 study.
Journal of Clinical Oncology·2024· 16 cited
Abstract CT202: CSFctDNA as a surrogate for tumor tissue DNA in BC pts with CNS metastases: First results from the Brainstorm program (Oncodistinct 006)
Cancer Research·2024· 1 citedOpen Access
Référentiel national de traitement des carcinomes épidermoïdes des voies aérodigestives supérieures – Principes généraux de traitement
Bulletin du Cancer·2024· 1 cited
Prognostic value of circulating short-length DNA fragments in unresected glioblastoma patients
Translational Oncology·2024· 2 citedOpen Access
Référentiel national de traitement des carcinomes épidermoïdes des voies aérodigestives supérieures
Bulletin du Cancer·2024
page 1 of 13Next →

Frequent Co-authors

Frédéric Di Fiore(10), Matteo Lambertini(9), Anne Perdrix(8), Nasrin Sarafan‐Vasseur(8), Thibault De La Motte Rouge(7), Fabrice Jardin(7), David Sefrioui(7), Ludivine Beaussire(7), François‐Clément Bidard(6), Anne‐Claire Hardy‐Bessard(6), Florence Dalenc(6), Thomas Bachelot(6), Luís Teixeira(6), Suzette Delaloge(6), Isabelle Demeestere(6), Fedro A. Peccatori(6), Olivier Rigal(6), Cécile Guillemet(6), Marianne Leheurteur(6), Jean‐Michel Picquenot(6)